Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02108028
Recruitment Status : Recruiting
First Posted : April 9, 2014
Last Update Posted : November 25, 2020
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )

Tracking Information
First Submitted Date April 5, 2014
First Posted Date April 9, 2014
Last Update Posted Date November 25, 2020
Actual Study Start Date April 3, 2014
Estimated Primary Completion Date December 30, 2021   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: May 1, 2020)
perceived helpfulness and create changes [ Time Frame: 2 Months ]
To determine whether engaging in advance care planning using VMC is associated with reduced anxiety, improved social support, increased acceptance of illness and/or improved communication about ACP with family, friends and/or health care providers.
Original Primary Outcome Measures
 (submitted: April 5, 2014)
Preceived helpfulness [ Time Frame: 2 Months ]
Change History
Current Secondary Outcome Measures
 (submitted: December 19, 2017)
  • Helpfulness vs living & parental status [ Time Frame: 2 Months ]
    To examine the helpfulness of VMC by living status (independent living vs. with family of origin) and parental status.
  • Benefit vs Burden [ Time Frame: 2 Months ]
    To examine the perceived benefit and burden of completing VMC.
  • Feasibility [ Time Frame: 2 Months ]
    To assess whether further revisions are needed to VMC for use with YA
Original Secondary Outcome Measures
 (submitted: April 5, 2014)
  • Helpfulness vs living & amp; parental status [ Time Frame: 2 Months ]
  • Benefit vs Burden [ Time Frame: 2 Months ]
  • Asses VMC version [ Time Frame: 2 Months ]
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer
Official Title An Exploratory Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer and Other Chronic Illnesses
Brief Summary

Background:

- There are very few documents to help young adults living with advanced cancer discuss their concerns and end-of-life preferences. A new document, Voicing My CHOiCES, allows young adults to explain what kind of care they would want if they became unable to communicate or make medical decisions on their own. Researchers want to study if this document is helpful.

Objective:

- To study if Voicing My CHOiCES can reduce anxiety, improve sense of support, and improve communication about advanced care planning.

Eligibility:

- Adults 18 to 39 years old being treated for cancer.

Design:

  • Participants will answer questions about their age, gender, employment, religion, health, and marital status. They will also complete several brief questionnaires:

    1. General Anxiety Short Form
    2. Peace, Equanimity and Acceptance in the Cancer Experience
    3. Functional Assessment of Social Support
    4. Quality of Communication
    5. Prior Communication about Advanced Care Planning
  • Then a health care professional will introduce Voicing My CHOiCES . Participants will review the document and comment on parts they find relevant. They will also say if any important items are missing. Participants will complete 3 pages of the document with the assistance of a health care provider. They will be asked for positive and negative observations.
  • The second stage of the study will take place about 1 month later. Participants will repeat the brief questionnaires listed above. They will be asked if they shared any of the preferences they described when completing the 3 pages of Voicing My CHOiCES during visit 1 with a family member, friend, or health care provider. Research staff will ask the participant for permission to contact the people they spoke with in order to learn whether their conversations about the document were helpful. They will ask for feedback on how to make Voicing My CHOiCES more helpful.
Detailed Description

Background:

  • Discussing end-of-life (EoL) care is very challenging for young adults (YA) living with a life threatening disease.
  • While many helpful documents exist to facilitate EoL conversations with adults, few resources exist to aid YA in understanding and accepting their changing physical, emotional and social needs when treatment is no longer effective.
  • Between 2007-2011, the Pediatric Oncology Branch (07-C-0085) explored the helpfulness of Five Wishes with adolescents and young adults living with HIV or advanced cancer. Thisresearch led to the development of a new advance care planning (ACP) guide, Voicing My CHOiCES (VMC). However, Voicing My CHOiCES has not been empirically examined in its completed form.

Objectives:

  • To determine the perceived helpfulness of VMC.
  • To determine whether engaging in advanced care planning using VMC is associated with reduced anxiety, improved social support, increased acceptance of illness, and/or improved communication about ACP with family, friends, and/or health care providers.
  • To assess the helpfulness of the changes made to the original VMC as compared to the revised VMC document.

Eligibility:

  • Patient Participants:
  • Age: 18 through 39 years
  • Known cancer or other chronic illness and enrolled on an NIH protocol or treated at one of the participating sites.
  • No prior experience using Voicing My CHOiCES
  • Patients and family/friend and health care providers must be English or Spanish speaking. Participants enrolled to assess the helpfulness of changes made to original VMC must be English speaking.

Design:

  • Each subject will complete a baseline assessment of their anxiety pertaining to advance care planning, quality of social support, acceptance of illness,and quality of communication with family, friends and health care providers. They will be asked to review the advance care planning document, Voicing My CHOiCES , and to comment on each section as to whether it can provide an opportunity to address ACP needs for themselves and for other YA their age living with a serious illness. They will also assess whether revisions are needed to the document.
  • To obtain the perspectives of different YA, the initial study cohort will include up to 130 participants, with a minimum of 25 YA who are living independently and 25 YA who have a child(ren) of their own. In addition, up to 100 family/friends and health care providers of the participants will participate in the follow up assessment. An additional 50 participants will be recruited, at the Clinical Center only, to compare the original Voicing My CHOiCES to the revised document. A total of up to 280 individuals may participate in this study.
  • A 1-month pre-post design will be used to assess the utility of the document, anxiety, quality of social support, acceptance of illness, communication about EoL planning, and whether the patient participant has shared any of the work completed in the document with a family member, friend, or health care provider.

If the participant had shared the ACP preferences that were documented in Voicing My CHOiCES with a family member or friend, and had consented for us to contact that person, we will obtain the family member or friend s consent and complete a brief interview assessing the helpfulness and limitations of Voicing My CHOiCES for ACP. If the participant had shared the ACP preferences that were documented in Voicing My CHOiCES with their health care provider and had consented for us to talk with that health care provider, a brief interview assessing the helpfulness and limitations of Voicing My CHOiCES for end-of-life planning and whether any changes in the participants health care was made in response to Voicing My CHOiCES , will be documented.

Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Patients must be diagnosed with cancer or other chronic illness and enrolled on an NIH protocol or treated at one of the participating sites.@@@Non-Patient participants must be family/friend and/or health care providers of patients diagnosed with cancer or other chronic illness and enrolled on an NIH protocol or treated at one of the participating sites.
Condition
  • HIV
  • Cancer
  • Chronic Granulomatous Disease
  • Dock 8 Deficiency
Intervention Not Provided
Study Groups/Cohorts
  • Cohort 1A / Initial Young Adults with Children
    At least 25 young adults who have children and are 18 through 39 years diagnosed with cancer or other chronic illness and enrolled on an NIH protocol or treated at one of the participating sites.
  • Cohort 1B / Comparison Young Adults with Children
    At least 15 young adults who have children and are 18 through 39 years diagnosed with cancer or other chronic illness and enrolled on an NIH protocol.
  • Cohort 2A / Initial Independent Young Adults
    At least 25 young adults who live independently and are 18 through 39 years diagnosed with cancer or other chronic illness and enrolled on an NIH protocol or treated at one of the participating sites.
  • Cohort 2B / Comparison Independent Young Adults
    Up to 35 young adults who live independently and are 18 through 39 years diagnosed withcancer or other chronic illness and enrolled on an NIH protocol.
  • Cohort 3 / Non-patient participants
    Up to 100 family members, friends, or health care providers of patient participant
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Recruiting
Estimated Enrollment
 (submitted: May 1, 2020)
280
Original Estimated Enrollment
 (submitted: April 5, 2014)
200
Estimated Study Completion Date December 31, 2021
Estimated Primary Completion Date December 30, 2021   (Final data collection date for primary outcome measure)
Eligibility Criteria
  • ELIGIBILITY CRITERIA FOR PATIENT PARTICIPANTS (COHORT 1A, 1B, 2A and 2B):

INCLUSION CRITERIA:

  • Patients must be between ages: 18 through 39 years
  • Patients must be diagnosed with cancer or other chronic illness.
  • Patients must give informed consent.
  • Patients must have a score of 3 or less on the Eastern Cooperative Oncology Group Performance Status Scale (ECOG PS; Appendix
  • Patients must be English or Spanish speaking.

    • Cohorts 1B and 2B must be English speaking only.

EXCLUSION CRITERIA:

  • Presence of psychotic symptoms or severe psychological distress, which in the judgment of the Principal or Associate Investigator or consulting psychiatrist would compromise the patient s ability to engage in the intervention or is likely to interfere with the study procedures or results.
  • Cognitive impairment which in the judgment of the Principal or Associate Investigatorwould compromise the patient s ability to understand the VMC material or is likely to interfere with the study procedures or results.
  • Clinically significant, systemic illness (serious infections or significant cardiac, pulmonary, hepatic or other organ dysfunction) which in the judgment of the research team would compromise the patient s ability to tolerate or complete this study.
  • Participants who have already completed the Voicing My CHOiCES tool.

ELIGIBILITY CRITERIA FOR NON-PATIENT PARTICPANTS (COHORT 3):

INCLUSION CRITERIA:

  • Subject must be greater than or equal to 18 years of age
  • Family/friend and/or health care providers must be English or Spanish speaking.
  • Family/friend and health care providers must provide informed consent.
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years to 100 Years   (Adult, Older Adult)
Accepts Healthy Volunteers Yes
Contacts
Contact: Lori Wiener, Ph.D. (240) 760-6419 lori.wiener@nih.gov
Listed Location Countries United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT02108028
Other Study ID Numbers 140079
14-C-0079
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )
Study Sponsor National Cancer Institute (NCI)
Collaborators Not Provided
Investigators
Principal Investigator: Lori Wiener, Ph.D. National Cancer Institute (NCI)
PRS Account National Institutes of Health Clinical Center (CC)
Verification Date April 30, 2020